2001/75/EC: Commission Decision of 18 January 2001 for… Article 1

Article 1

1. The Community shall make arrangements for appropriate safety and potency testing of: - foot-and-mouth disease virus antigens purchased in 1993 and since then kept as a part of the EU emergency stock, - foot-and-mouth disease vaccine produced in Turkey and used in a prophylactic vaccination programme which includes vaccination of susceptible animals kept in the area of Turkish Thrace, - bluetongue vaccines produced outside the European Community and purchased for an emergency stock. 2. The maximum cost of the measures referred to in paragraph 1 shall be up to EUR 430000.